Cytogenetics Market to Reach $10.6 billion, Globally, by 2035 at 11.7% CAGR: Allied Market Research

Wilmington, Delaware, Feb. 05, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Cytogenetics Market by Product (Consumable, Instrument, Software and Service), by Technique (Comparative Genome Hybridization, Fluorescence in Situ Hybridization, Karyotyping, Others), by Application (Genetic Disorder, Cancer, Personalized Medicine, Others), by End User (Clinical and Research Laboratory, Pharmaceutical and Biotechnology Company, Academic Research Institute, Other): Global Opportunity Analysis and Industry Forecast, 2024-2035″. According to the report, the “cytogenetics market” was valued at $2.8 billion in 2023, and is estimated to reach $10.6 billion by 2035, growing at a CAGR of 11.7% from 2024 to 2035. 

Request Sample of the Report on Global Cytogenetics Market 2035 – https://www.alliedmarketresearch.com/request-sample/2116 

Prime determinants of growth 

Surge in prevalence of genetic disorders, rise in awareness and adoption of personalized medicine, and advancement in technology are the major factors that drive the growth of the cytogenetics market. However, the high costs of equipment and procedures restrict market growth. On the contrary, the increase in focus on research and development and high growth potential in emerging countries are expected to present new opportunities in the coming years. 

Report coverage & details: 

Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/2116 

The consumable segment to maintain its leadership status during the forecast period 

By product, the consumable segment held the largest market share in 2023, accounting for more than two-fifths of the cytogenetics market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the continuous and recurring demand for consumables such as reagents, probes, kits, and media used in various cytogenetic tests. The increasing volume of diagnostic and research activities, advancements in cytogenetic techniques like FISH and CGH, and the essential role these consumables play in ensuring accurate results drive the segment’s dominance. 

However, the software and service segment is expected to register the highest CAGR of 12.4% during the forecast period. This is attributed to increasing demand for advanced software solutions that enhance the efficiency, accuracy, and speed of cytogenetic testing and data analysis. In addition, the growing need for sophisticated data management systems, real-time analytics, and personalized medicine applications is driving demand for software and support services. 

The comparative genome hybridization segment to maintain its leadership status during the forecast period 

By technique, the comparative genome hybridization segment held the largest market share in 2023, accounting for around half of the cytogenetics market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 12.7% during the forecast period. This is attributed to the ability to detect chromosomal abnormalities and copy number variations with high accuracy and resolution, making it an essential tool for diagnosing genetic disorders and cancers. The growing prevalence of these conditions, combined with the increasing use of CGH in both clinical and research settings for comprehensive genomic analysis, drives its widespread adoption. 

The cancer segment held the largest market share in 2023 

By application, the cancer segment held the largest market share in 2023, accounting for around two-fifths of the cytogenetics market revenue and is estimated to maintain its leadership status throughout the forecast period owing to the increase in prevalence of various cancers and the critical role cytogenetic testing plays in cancer diagnosis and treatment. Cytogenetic techniques are widely used for detecting chromosomal abnormalities and genetic mutations associated with cancer. However, the personalized medicine segment is expected to register the highest CAGR of 13.1% during the forecast period. This is attributed to the rise in demand for personalized therapies, especially in areas like oncology, where genetic profiling plays a crucial role in developing targeted treatments. 

The clinical and research laboratory segment held the largest market share in 2023 

By end user, the clinical and research laboratory segment held the largest market share in 2023, accounting for more than one-third of the cytogenetics market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the continuous expansion of clinical applications, coupled with growing investments in genetic research and technological advancements in testing methods. However, the pharmaceutical and biotechnology company segment is expected to register the highest CAGR of 12.5% during the forecast period. This is attributed to the increasing use of cytogenetic technologies in drug discovery, development, and personalized medicine. Pharmaceutical and biotechnology companies are leveraging cytogenetic testing to identify genetic biomarkers, enhance target validation, and develop tailored therapies based on individual genetic profiles. 

North America to maintain its dominance by 2035  

North America dominated the market share in 2023, accounting for around half of the cytogenetics market revenue, owing to the region’s advanced healthcare infrastructure, high adoption of cutting-edge cytogenetic technologies, and substantial investments in research and development. However, Asia-Pacific is expected to register the highest CAGR of 12.8% during the forecast period owing to rapid economic development, increasing investments in healthcare infrastructure, growing focus on advancing medical technologies, and rising awareness and demand for personalized medicine, which drives the adoption of cytogenetic testing. 

For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/2116 

Leading Market Players 

• Applied Spectral Imaging 

• Thermo Fisher Scientific Inc.  

The report provides a detailed analysis of these key players in the cytogenetics market. These players have adopted strategies such as agreement, product launch, partnership, joint venture, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario. 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter